Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: Discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Feb 2019
Historique:
received: 21 11 2018
revised: 20 12 2018
accepted: 20 12 2018
pubmed: 30 12 2018
medline: 27 3 2019
entrez: 30 12 2018
Statut: ppublish

Résumé

An expanded set of diversely substituted 1,2,4-oxadiazole-containing primary aromatic sulfonamides was synthesized and tested for inhibition of human carbonic anhydrase I, II, IX and XII isoforms. The initial biochemical profiling revealed a significantly more potent inhibition of cancer-related, membrane-bound isoform hCA IX (reaching into submicromolar range), on top of potent inhibition of hCA XII that is another cancer target. The observed structure-activity relationships have been rationalized by molecular modeling. Comparative single-concentration profiling of the carbonic anhydrase inhibitors synthesized for antiproliferative effects against normal (ARPE-19) and cancer (PANC-1) cell lines under chemically induced hypoxia conditions revealed several candidate compounds selectively targeting cancer cells. More in-depth characterization of these leads revealed two structurally related compounds that showed promising selective cytotoxicity against pancreatic cancer (PANC-1) and melanoma (SK-MEL-2) cell lines.

Identifiants

pubmed: 30594030
pii: S0223-5234(18)31087-0
doi: 10.1016/j.ejmech.2018.12.049
pii:
doi:

Substances chimiques

Carbonic Anhydrase Inhibitors 0
Oxadiazoles 0
Sulfonamides 0
Carbonic Anhydrase IX EC 4.2.1.1
Carbonic Anhydrases EC 4.2.1.1
carbonic anhydrase XII EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-105

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

Mikhail Krasavin (M)

Saint Petersburg State University, Saint Petersburg, 199034, Russian Federation. Electronic address: m.krasavin@spbu.ru.

Anton Shetnev (A)

The Ushinsky Yaroslavl State Pedagogical University, Yaroslavl, 150000, Russian Federation.

Tatyana Sharonova (T)

Saint Petersburg State University, Saint Petersburg, 199034, Russian Federation.

Sergey Baykov (S)

Saint Petersburg State University, Saint Petersburg, 199034, Russian Federation.

Stanislav Kalinin (S)

Saint Petersburg State University, Saint Petersburg, 199034, Russian Federation.

Alessio Nocentini (A)

Neurofarba Department, Universita degli Studi di Firenze, Florence, Italy.

Vladimir Sharoyko (V)

Saint Petersburg State University, Saint Petersburg, 199034, Russian Federation.

Giulio Poli (G)

Department of Pharmacy, University of Pisa, 56126, Pisa, Italy.

Tiziano Tuccinardi (T)

Department of Pharmacy, University of Pisa, 56126, Pisa, Italy.

Sofia Presnukhina (S)

The Ushinsky Yaroslavl State Pedagogical University, Yaroslavl, 150000, Russian Federation.

Tatiana B Tennikova (TB)

Saint Petersburg State University, Saint Petersburg, 199034, Russian Federation.

Claudiu T Supuran (CT)

Neurofarba Department, Universita degli Studi di Firenze, Florence, Italy. Electronic address: claudiu.supuran@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH